Companies: 10,795·Total market cap: $144.5T

DaVita Inc.

DaVita Inc.

DVANYSEHealthcare● Active

$192.16

$-0.01(-0.01%)

Market Cap$12.3B

P/E Ratio—

52W High$202.69

52W Low$101

Avg Volume879K

Open$193.21

Beta0.91

股票排行：Medical - Care Facilities·Healthcare·查看全部市值排行 →

DaVita Inc.（DVA）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · DVA · 截至 Jun 8, 2026

关键指标

EPS (TTM)$10.15Earnings history

PE Ratio (TTM)18.9×PE Ratio deep dive

Revenue (TTM)$13.8BFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding86.1MShares outstanding history

Next EarningsAug 5, 2026Est.Earnings history

探索 DaVita Inc. 数据

分析师预测$202 · Hold

股息不分红

营收$13.6B+6.46%

盈利EPS $9.72-11.80%

市盈率18.9×

财务快照

FY 2025Revenue$13.64B▲ +6.46% YoY

202320242025

FY 2025Net Income$746.8M▼ 20.24% YoY

202320242025

FY 2025EPS$9.72▼ 11.80% YoY

202320242025

TTM:Revenue: $13.84BNet Income: $781.4MEPS: $10.15View income statement →

分析师评级与目标价

Hold23 位分析师

Strong Buy

0

Buy

9

Hold

13

Sell

1

Strong Sell

0

12-Month Price Target

$190.00Low

$192.16Current

$202.25Avg Target上涨空间 5.25%

$220.00High

合计: 23 · 买入占比: 39.1%

根据过去 3 个月内 23 位华尔街分析师，DVA 共识评级为 Hold，12 个月平均目标价 $202.25 （较现价 $192.16 上涨空间 5.25%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

$192.16-0.01%$12.3B #2

Align Technology, Inc.

$167.74-0.33%$12.0B #3

AptarGroup, Inc.

$113.36+0.72%$7.2B #4

Bio-Rad Laboratories, Inc.

$294.32-4.28%$8.0B #5

BioMarin Pharmaceutical Inc.

$56.77+0.53%$11.0B #6

Chemed Corporation

$441.59+2.14%$5.9B

股票表现

1D-0.01%

1W+1.95%

1M-3.27%

3M+27.46%

YTD+69.14%

1Y+39.47%

5Y+60.84%

关于 DaVita Inc.

CEOJavier J. Rodriguez

IPO DateOct 31, 1995

Employees76,000

CountryUS

Websitedavita.com

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis …

Medical - Care Facilities HealthcareNYSEUS

关于股票概览与关键数据

DaVita Inc.（DVA）是 Medical - Care Facilities 行业的 Healthcare 类公司，于 Oct 31, 1995 在 NYSE 上市。截至最近交易日，DVA 股价为 $192.16，市值约为 $12.3B。过去12个月累计回报 +39.47%，年初至今回报 +69.14%。

根据 23 位华尔街分析师，DaVita Inc. 股票共识评级为Hold，12个月平均目标价为 $202.25。2025 财年 DaVita Inc. 营收 $13.6B，净利润 $746.8M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，DaVita Inc.（DVA）股价为 $192.16，在 NYSE 上市，52周区间为 $101.00 – $202.69。

DVA 最新股价DVA quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议